184 related articles for article (PubMed ID: 33554762)
1. A novel antiplasmodial compound: integration of
Costa Júnior DB; Araújo JSC; Oliveira LM; Neri FSM; Moreira POL; Taranto AG; Fonseca AL; Varotti FP; Leite FHA
J Biomol Struct Dyn; 2022 Sep; 40(14):6295-6307. PubMed ID: 33554762
[TBL] [Abstract][Full Text] [Related]
2. Structure-Based Design and Pharmacophore-Based Virtual Screening of Combinatorial Library of Triclosan Analogues Active against Enoyl-Acyl Carrier Protein Reductase of
Bieri C; Esmel A; Keita M; Owono LCO; Dali B; Megnassan E; Miertus S; Frecer V
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108083
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel antiplasmodial compound by hierarquical virtual screening and
Costa Júnior DB; Araújo JSC; de Mattos Oliveira L; Neri FSM; Moreira POL; Taranto AG; Fonseca AL; de Pilla Varotti F; Leite FHA
J Biomol Struct Dyn; 2021 Jun; 39(9):3378-3386. PubMed ID: 32364060
[TBL] [Abstract][Full Text] [Related]
4. Celastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductase.
Tallorin LC; Durrant JD; Nguyen QG; McCammon JA; Burkart MD
Bioorg Med Chem; 2014 Nov; 22(21):6053-6061. PubMed ID: 25284249
[TBL] [Abstract][Full Text] [Related]
5. Identification of natural products against enoyl-acyl-carrier-protein reductase in malaria via combined pharmacophore modeling, molecular docking and simulations studies.
Manhas A; Ghosh A; Verma Y; Das T; Jha PC
J Biomol Struct Dyn; 2023 Mar; 41(5):2002-2015. PubMed ID: 35043754
[No Abstract] [Full Text] [Related]
6. Molecular modeling studies, synthesis, and biological evaluation of Plasmodium falciparum enoyl-acyl carrier protein reductase (PfENR) inhibitors.
Morde VA; Shaikh MS; Pissurlenkar RR; Coutinho EC
Mol Divers; 2009 Nov; 13(4):501-17. PubMed ID: 19347595
[TBL] [Abstract][Full Text] [Related]
7. In silico screening for Plasmodium falciparum enoyl-ACP reductase inhibitors.
Lindert S; Tallorin L; Nguyen QG; Burkart MD; McCammon JA
J Comput Aided Mol Des; 2015 Jan; 29(1):79-87. PubMed ID: 25344312
[TBL] [Abstract][Full Text] [Related]
8. In silico evaluation and in vitro growth inhibition of Plasmodium falciparum by natural amides and synthetic analogs.
da Silva MA; Veloso MP; de Souza Reis K; de Matos Passarini G; Dos Santos APA; do Nascimento Martinez L; Fokoue HH; Kato MJ; Teles CBG; Kuehn CC
Parasitol Res; 2020 Jun; 119(6):1879-1887. PubMed ID: 32382989
[TBL] [Abstract][Full Text] [Related]
9. SAR and pharmacophore models for the rhodanine inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase.
Kumar G; Banerjee T; Kapoor N; Surolia N; Surolia A
IUBMB Life; 2010 Mar; 62(3):204-13. PubMed ID: 20131353
[TBL] [Abstract][Full Text] [Related]
10. Benzothiophene carboxamide derivatives as inhibitors of Plasmodium falciparum enoyl-ACP reductase.
Banerjee T; Sharma SK; Kapoor N; Dwivedi V; Surolia N; Surolia A
IUBMB Life; 2011 Dec; 63(12):1101-10. PubMed ID: 22006792
[TBL] [Abstract][Full Text] [Related]
11. Identification of PfENR inhibitors: A hybrid structure-based approach in conjunction with molecular dynamics simulations.
Manhas A; Patel A; Lone MY; Jha PK; Jha PC
J Cell Biochem; 2018 Nov; 119(10):8490-8500. PubMed ID: 30105881
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, structural characterization by IR, (1) H, (13) C, (15) N, 2D-NMR, X-ray diffraction and evaluation of a new class of phenylaminoacetic acid benzylidene hydrazines as pfENR inhibitors.
Samal RP; Khedkar VM; Pissurlenkar RR; Bwalya AG; Tasdemir D; Joshi RA; Rajamohanan PR; Puranik VG; Coutinho EC
Chem Biol Drug Des; 2013 Jun; 81(6):715-29. PubMed ID: 23398677
[TBL] [Abstract][Full Text] [Related]
13. Virtually Designed Triclosan-Based Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis and of Plasmodium falciparum.
Owono Owono LC; Ntie-Kang F; Keita M; Megnassan E; Frecer V; Miertus S
Mol Inform; 2015 May; 34(5):292-307. PubMed ID: 27490275
[TBL] [Abstract][Full Text] [Related]
14. Towards development of new antimalarial compounds through in silico and in vitro assays.
Junior DBC; Lacerda PS; de Pilla Varotti F; Leite FHA
Comput Biol Chem; 2024 Aug; 111():108093. PubMed ID: 38772047
[TBL] [Abstract][Full Text] [Related]
15. Discovery of new potential hits of Plasmodium falciparum enoyl-ACP reductase through ligand- and structure-based drug design approaches.
Neves BJ; Bueno RV; Braga RC; Andrade CH
Bioorg Med Chem Lett; 2013 Apr; 23(8):2436-41. PubMed ID: 23499236
[TBL] [Abstract][Full Text] [Related]
16. Prioritization of active antimalarials using structural interaction profile of Plasmodium falciparum enoyl-acyl carrier protein reductase (PfENR)-triclosan derivatives.
Kumar SP; George LB; Jasrai YT; Pandya HA
SAR QSAR Environ Res; 2015; 26(1):61-77. PubMed ID: 25567142
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin gallate is a slow-tight binding inhibitor of enoyl-ACP reductase from Plasmodium falciparum.
Banerjee T; Sharma SK; Surolia N; Surolia A
Biochem Biophys Res Commun; 2008 Dec; 377(4):1238-42. PubMed ID: 18992222
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of Plasmodium falciparum enoyl-ACP reductase and implications on drug discovery.
Lindert S; McCammon JA
Protein Sci; 2012 Nov; 21(11):1734-45. PubMed ID: 22969045
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel inhibitors targeting enoyl-acyl carrier protein reductase in Plasmodium falciparum by structure-based virtual screening.
Nicola G; Smith CA; Lucumi E; Kuo MR; Karagyozov L; Fidock DA; Sacchettini JC; Abagyan R
Biochem Biophys Res Commun; 2007 Jul; 358(3):686-91. PubMed ID: 17509532
[TBL] [Abstract][Full Text] [Related]
20. Combined 3D-QSAR and Molecular Docking Study for Identification of Diverse Natural Products as Potent Pf ENR Inhibitors.
Wadhwa P; Saha D; Sharma A
Curr Comput Aided Drug Des; 2015; 11(3):245-57. PubMed ID: 26517356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
